Industry Insight
Discovery Technology
Analytical Laboratory Technology
Biopharma
Manufacturing
Delivery Systems
Ingredients, Formulation and Finishing
Bioprocessing
View our other publications with free access to extensive archives
  To print this article:
Existing subscribers please log in:
 
  USER NAME  
  PASSWORD  
   Or select

Or become a subscriber
 
 
 

Opportunities for niche players in the combinatori

Pharmaceutical companies direct R&D investment is being increasingly focused on the core business - leaving space for niche suppliers in areas such as combinatorial chemistry.

Linda Hugl, Ian Matthews and Alan Stuttle, ChemOva (June 2000)

Keywords: chemical assay, camd, compound management systems, hplc, histology, chromatography, luminescence, electrophoresis, ftir, luminescence technology, molecule development, microscopy, nature, quantitative neuroimaging, screening, radio-labelled studies, research, spectroscopy, lc-gc, synthesis, microscopy and analysis, laboratory, molecules, ChemOvation Ltd, Jeté, R&D

    View full article    |    Back to Discovery Technology section




Advair,Flovent,VentolinSymbicort,Serevent,FlonaseAstelin Rhinocort
IPTonline © 2004 The Pharmaceutical Technology Journal | Terms and Conditions | info@iptonline.com | UK Contacts |
Providing a platform of communication on new ideas, developments and innovations | UK Tel No. +44 20 77243456 | Back to top of page |